C12N 2760/00023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/00023 (Virus like particles [vlp]) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 6
- Inventors
- 15
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cyclic peptides for protection against respiratory syncytial virus17 Feb 2026US 12,552,839 B2UniversitäT ZüRich
- Cyclic peptides for protection against respiratory syncytial virus20 Jun 2023US 11,680,085 B2UniversitäT ZüRich
- Treatment of canine atopic dermatitis16 Mar 2021US 10,946,078 B2Benchmark Animal Health Limited
- Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS30 Dec 2014US 8,920,812 B2Takeda Vaccines, Inc.
- Cyclic peptides for protection against respiratory syncytial virus29 Aug 2024US 2024/0287143 A1UniversitäT ZüRich
- Cyclic peptides for protection against respiratory syncytial virus8 Apr 2021US 2021/0101941 A1UniversitäT ZüRich
- Treatment of canine atopic dermatitis11 Jul 2019US 2019/0209668 A1Benchmark Animal Health Limited
- Construction and application of one innovative expression vector for virus-like particles10 May 2018US 2018/0127837 A1Chinese Academy of Inspection and Quarantine
- Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps23 Aug 2012US 2012/0213817 A1Ligocyte Phamaceuticals, Inc.
Most cited
By later US patents